Physician profile
David J Cox
NPI 1417102393
$359.15
in general payments reported to CMS, 2019-2025
13 companies · $28.81 in 2025
The $28.81 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.45 · 2021: $43.22 · 2022: $74.73 · 2023: $64.88 · 2024: $134 · 2025: $28.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $49.40 | 2024 | Rybelsus |
| Janssen Pharmaceuticals, INC | $35.51 | 2023-2024 | Xarelto |
| Pfizer INC. | $34.66 | 2020-2022 | |
| Amgen INC. | $33.53 | 2021-2022 | |
| Abbvie INC. | $29.11 | 2024 | |
| Stryker Corporation | $28.81 | 2025 | Clottriever Bold Catheter |
| Novartis Pharmaceuticals Corporation | $24.51 | 2024 | |
| Horizon Therapeutics Plc | $23.99 | 2021 | |
| Quidel Corporation | $23.06 | 2023 | |
| Inari Medical, INC. | $22.50 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $20.33 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.89 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.85 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.